Myocardial matrix metalloproteinase activity and abundance with congestive heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Coker, Mytsi L ^a   Thomas, Chadwick V ^a   Clair, Mark J ^a   Hendrick, Jennifer W ^a   Krombach, R Stephen ^a   Galis, Zorina S ^b   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Left ventricle

Indexed keywords

COLLAGEN; COLLAGENASE; GELATINASE A; HEART ENZYME; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SWINE;

EID: 33750823485     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.5.h1516     Document Type: Article

References (40)

1. Armstrong, P., G. Moe, R. Howard, E. Grima, and T. Cruz. Structural remodelling in heart failure: gelatinase induction. Can. J. Cardiol. 10: 214-220, 1994.
2. Barletta, J., G. Angella, K. Balch, H. Dimova, G. Stern, M. Moser, G. Setten, and G. Schultz. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest. Opthalmol. Visual Sci. 37: 20-28, 1996.
3. Benedict, C. R., D. H. Weiner, D. E. Johnstone, M. G. Bourassa, J. K. Ghali, J. Nicklas, P. Kirlin, B. Greenberg, M. A. Quinones, and S. Yusuf for the SOLVD Investigators. Comparative neurohormonal responses in patients with preserved, and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry. J. Am. Coll. Cardiol. 22: 146A-153A, 1993.
4. Bergman, U., A. Tuuttila, W. Stetler-Stevenson, and K. Tryggvason. Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry 34: 2819-2825, 1995.
5. Birkedal-Hansen, H., W. Moore, M. Bodden, L. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J. Engler. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250, 1992.
6. Bjerrum, O., J. Selmer, and A. Lihme. Native immunoblotting: transfer of membrane proteins in the presence of nonionic detergent. Electrophoresis 8: 388-397, 1987.
7. Burnette, W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose, and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 105-203, 1981.
8. Caulfield, J., and T. Borg. The collagen network of the heart. Lab. Invest. 40: 364-372, 1979.
9. Cintron, G., G. Johnson, G. Francis, F. Cobb, and J. Cohn for the V-HeFt VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 87, Suppl. VI: VI-17-VI-23, 1993.
10. Cohn, J., G. Johnson, R. Shabetai, H. Loeb, F. Tristani, T. Rector, R. Smith, and R. Fletcher for the V-HeFt VA Cooperative Studies Group. Ejection fraction, peak exercise, oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 87, Suppl. VI: VI-5-VI-16, 1993.
11. Damiano, R., H. Tripp, T. Asano, K. Small, R. Jones, and J. Lowe. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J. Thoracic Cardiovasc. Surg. 94: 135-143, 1987.
12. Galis, Z., M. Muszynski, G. Sukhova, E. Simon-Morrissey, E. Unemori, M. Lark, E. Amento, and P. Libby. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75: 181-189, 1994.
13. Galis, Z., G. Sukhova, M. Larck, and P. Libby. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503, 1994.
14. Grobelny, D., L. Poncz, and R. Galardy. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31: 7152-7154, 1992.
15. Guerin, C., and P. Holland. Synthesis and secretion of matrix-degrading metalloproteinases by human skeletal muscle satellite cells. Dev. Dynam. 202: 91-99, 1995.
16. Gunja-Smith, Z., A. Morales, R. Romanelli, and J. Woessner. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Am. J. Pathol. 148: 1639-1648, 1996.
17. Gruber, B., M. Marchese, K. Suzuki, L. Schwartz, Y. Okada, H. Nagase, and N. Ramamurthy. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinases activation. J. Clin. Invest. 84: 1657-1662, 1989.
18. He, C., S. Wilheilm, A. Pentland, B. Marmer, G. Grant, A. Eisen, and G. Goldberg. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA 86: 2632-2636, 1989.
19. Heussen, C., and E. Dowdle. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196-202, 1980.
20. Iannini, J. P., and F. G. Spinale. The identification of contributory mechanisms for the development and progression of congestive heart failure using animal models. J. Heart Lung Transplant. 15: 1138-1150, 1996.
21. Kleiner, D., and W. Stetler-Stevenson. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218: 325-329, 1994.
22. Komamura, K., R. Shannon, T. Ihara, Y. Shen, I. Mirsky, S. Bishop, and S. Vatner. Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1119-H1131, 1993.
23. Konstam, M., M. Kronenberg, M. Rousseau, J. Udelson, J. Melin, D. Stewart, N. Dolan, T. Edens, S. Ahn, D. Kinan, D. Howe, L. Kilcoyne, J. Metherall, C. Benedict, S. Yusuf, and H. Pouler. Effects of angiotensin converting enzyme on the long-term progression of left ventricular dilation in patients with asymptomatic systolic dysfunction. Circulation 88: 2277-2283, 1993.
24. Lark, M., L. Walakovits, T. Shah, J. Vanmiddlesworth, P. Cameron, and T. Lin. Production and purification of prostromelysin and procollagenase from IL-1 beta-stimulated human gingival fibroblasts. Connect. Tissue Res. 25: 49-65, 1990.
25. Morodomi, T., Y. Ogata, Y. Sasaguri, M. Morimatsu, and H. Nagase. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukemia and HT 1080 fibrosarcoma cells. Biochem. J. 285: 603-611, 1992.
26. Murphy, G., M. Cockett, P. Stephens, B. Smith, and A. Docherty. Stromelysin is an activator of procollagenase. Biochem. J. 248: 265-268, 1987.
27. Nagase, H., J. Enghild, K. Suzuki, and G. Salvesen. Stepwise activation mechanisms of the precursor of the matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503, 1994.
28. Okada, Y., Y. Gonoji, K. Naka, K. Tomita, I. Nakanishi, K. Iwata, K. Yamashita, and T. Hayakawa. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J. Biol. Chem. 267: 21712-21719, 1992.
29. Robinson, T., L. Cohen-Gould, and S. Factor. Skeletal framework of mammalian heart muscle: arrangement of inter- and pericellular connective tissue structures. Lab. Invest. 49: 482-498, 1983.
30. Spinale, F. Pacing tachycardia-induced congestive heart failure. Heart Failure 11: 219-232, 1995.
31. Spinale, F., M. Tomita, J. Zellner, J. Cook, F. Crawford, and M. Zile. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H308-H318, 1991.
32. Tomita, M., F. Spinale, F. Crawford, and M. Zile. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy: disparity between recovery of systolic vs. diastolic function. Circulation 83: 635-644, 1991.
33. Tyagi, S., S. Campbell, H. Reddy, E. Tjahja, and D. Voelker. Matrix metalloproteinase activity and expression in infarcted, noninfarcted, and dilated cardiomyopathic human hearts. Mol. Cell. Biochem. 155: 13-21, 1996.
34. Tyagi, S., A. Ratajska, and K. Weber. Myocardial matrix metalloproteinases: localization and activation. Mol. Cell. Biochem. 126: 49-59, 1993.
35. Weber, K. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 13: 1637-1652, 1989.
36. Weber, K., R. Pick, J. Janicki, G. Gadodia, and J. Lakier. Inadequate collagen tethers in dilated cardiomyopathy. Am. Heart J. 116: 1641-1646, 1988.
37. Werb, Z., and C. Alexander. Proteinases and matrix degradation. In: Textbook of Rheumatology, edited by W. N. Kelly. Philadelphia, PA: Saunders, 1993, p. 248-268.
38. Wilson, J., P. Douglas, W. Hickey, V. Lanoce, N. Ferraro, A. Muhuammad, and N. Reichek. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 75: 857-867, 1987.
39. Woessner, J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154, 1991.
40. Ye, Q., D. Hupe, and L. Johnson. Catalytic domains of matrix metalloproteinases: a molecular biology approach to drug discovery. Curr. Med. Chem. 3: 407-418, 1996.